Asia Pacific Bone Densitometer Devices Market

Asia Pacific Bone Densitometer Devices Market Size (2023 to 2028)

The size of the Asia Pacific Bone Densitometer Devices Market is predicted to hike at a steady rate from 2023 to 2028.

MARKET DRIVERS:

According to WHO, in 2022, Musculoskeletal impairments comprise more than 150 different diseases/conditions that affect the system and are characterized by impairments in the muscles, bones, joints, leading to temporary or lifelong limitations in functioning and participation. By forecasting countries in the WHO Western Pacific Region, the market estimation in the Asia Pacific region is 427 million. In Southeast Asia, 369 million people suffer from musculoskeletal conditions. According to WHO statistics, approximately 1.71 billion people face musculoskeletal conditions worldwide. Musculoskeletal conditions are a leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Rising population growth and aging, as well as the number of people with osteoporosis, osteogenesis, kidney disease, and other chronic diseases, affect and accelerate the growth of the bone densitometer market. The rise in the importance of dual-energy x-ray absorptiometry, ultrasound technology, and government initiatives for responding to the burden attributed to new programmatic areas, such as awareness programs for the measurement of bone density, are prone to influence the market growth. While in some circumstances, like childhood auto-immune inflammatory conditions such as juvenile arthritis, younger people are also affected and influence the market. While the prevalence of bone densitometer devices market conditions varies by age and diagnosis, people of all ages worldwide are affected.

Several Government agencies are taking initiatives by implementing awareness programs for the measurement of bone density for diagnosis of bone-associated disease, which is expected to create growth opportunities for the bone densitometer market in Asia-Pacific. The rise in the importance of ultrasound techniques is expected to create growth opportunities. Also, Industries are likely to explore different opportunities for developing innovative interventions such as patented narrow-fan beams. The rising advancements in technological procedures are making diagnosis simple by emitting rapid results, which is expected to provide market growth opportunities in the forecast period.

MARKET RESTRAINTS:

The high cost of the affected bone densitometer treatment plan and unfavorable reimbursement policies impacted the market growth. Lack of equipment like imaging devices for diagnostics and hospital facilities will challenge the bone densitometer devices market. Also, the need for more awareness and shortage of experienced hospital staff and specialists, particularly for bone densitometers, impacts the market. All these factors are restraining the bone densitometer market.

The major restraining factor for bone densitometer is DXA underutilization, which is concerning because of both its critical role in pre-fracture assessment and its importance for clinical procedures in treatments such as Fracture risk assessment tools. Another challenging aspect is the need for more awareness, and facilities are challenging for the diagnosis of disease. These factors are estimated to be restraining market expansion across the Asia-Pacific region.

COVID-19 Impact on Asia Pacific Bone Densitometer Devices Market:

The COVID-19 drastically increased the bone densitometer market. According to the article published by the National Library of Medicine in April 2022, Post-acute sequela of COVID-19 can cause secondary osteoporosis, which adversely affects bone health. With the increased number of COVID-19 patients, early detection and bone examination have increased, leading to increased demand for bone densitometers. To help with the early detection of osteoporosis problems, the bone health status of patients who survived COVID-19 was extensively examined at subsequent visits. Hence, These COVID-19 circumstances have influenced the market’s growth pace

The Asia Pacific Bone Densitometer Devices Market has been segmented and sub-segmented into the following categories:

Asia Pacific Bone Densitometer Devices Market - By Speciality:

• Cardiology
• Dermatology
• Neurology
• Orthopaedics
• Emergency Care
• Gynecology

The orthopedics segment held the largest market share in the regional market due to the increasing application of bone densitometers in the ortho. This segment is estimated to witness significant growth over the forecast period.

Asia Pacific Bone Densitometer Devices Market - By Services:

• Tele-Consultation
• Tele-Monitoring
• Tele-Education
• Tele-Surgery
• Tele-Training

The teleconsultation segment dominated the market due to the increased adoption of online services and technology. Tele-consultation helps by consulting doctors from remote areas to get information regarding diagnostic or therapeutic advice. Tele-monitoring and tele-education are expected to have steady growth over the forecast period.

Asia Pacific Bone Densitometer Devices Market - By End Users:

• Hospitals
• Clinics

The hospital segment held the largest market share as most cases are noted at hospitals due to their excellent healthcare infrastructure with advanced technology equipment. The hospital covers most of the insurance and reimbursement policies compared to clinics, influencing people to visit hospitals with highly qualified health professionals. All these factors boost market growth.

Regional Analysis:

The Asia-Pacific Bone Densitometer Devices Market is expected to grow at the highest pace in the future because of developing countries like India, China, and Japan.

The Bone densitometer devices market of the APAC region is anticipated to have rapid growth with the highest market share in the region. China is leading the market with the largest share and high revenue due to the high population and increasing cases of osteoporosis, the growing fracture risks, and increased life expectancy driving market growth. In countries like South Korea and Japan, a South Korean-based company, OsteoSys Corp, has a strong product portfolio of high-tech bone mineral density scan machines used for diagnosis purposes. Whereas in Japan, the healthcare system quality meets international standards. Additionally, hospitals and clinical segments are increasing awareness programs of bone densitometer, influencing the regional market growth during the forecast period.

Many patients are admitted to hospitals for various treatments like bone tumors, bone infections, etc. Additionally, the cost of bone densitometry is low and affordable and, therefore, increasingly preferred by patients, boosting the market growth in the Asia Pacific region.

Major companies leading the Asia Pacific Bone Densitometer Devices Market are Lone Oak Medical Technologies LLC, GE Healthcare, Osteometer Meditech, Hologic Inc., Beammed, Medonica Co. Ltd., Swissray International Inc., Diagnostic Medical System SA, and Osteosys Co. Ltd.